DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons
Business Model:
Revenue: $16.8M
Employees: 11-50
Address: 14612 Big Basin Way
City: Saratoga
State: CA
Zip: 95070
Country: US
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Contact Phone:
+16503291999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2012 | iScience Interventional | Venture Round | 2.8M |
5/2010 | TearScience | Series C | 44.5M |
9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
2/2011 | TRIA Beauty | Venture Round | 26.3M |
10/2012 | TRIA Beauty | Venture Round | 7.5M |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
4/2016 | TearScience | Series D | 0 |
2/2009 | WaveTec Vision | Series C | 20.1M |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
6/2012 | Astute Medical | Series C | 40.4M |
5/2011 | WaveTec Vision | Series D | 15.9M |
5/2007 | WaveTec Vision | Series B | 13M |
4/2011 | Benvenue Medical | Series C | 35.5M |
5/2018 | Avedro | Series F | 0 |
6/2014 | Spinal Kinetics | Venture Round | 34M |
1/2006 | Spinal Modulation | Series A | 7M |
3/2010 | Pulmonx | Series C | 0 |
6/2009 | Spiracur | Series B | 20.3M |
1/2012 | Pulmonx | Private Equity Round | 0 |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
1/2007 | Ovalis | Series B | 0 |
11/2009 | EndoGastric Solutions | Series E | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
1/2007 | TearScience | Series B | 15.1M |
1/2023 | Milo | Series A | 0 |
5/2005 | Talima Therapeutics | Series A | 1.6M |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
7/2006 | InSound Medical | Series E | 18.9M |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
5/2008 | Astute Medical | Series A | 6.3M |
3/2013 | Avedro | Series D | 0 |
1/2008 | Benvenue Medical | Series B | 15M |
2/2008 | InSound Medical | Series E | 11M |
11/2009 | Spinal Modulation | Series C | 27.4M |
6/2014 | Benvenue Medical | Series E | 40M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
7/2007 | CardioMind | Series C | 11M |
4/2003 | iScience Interventional | Series C | 15M |
6/2012 | Benvenue Medical | Series D | 25M |
3/2008 | CardioMind | Venture Round | 22M |
12/2009 | EBR Systems | Venture Round | 15M |
3/2004 | Spinal Kinetics | Series A | 10M |
2/2009 | SynergEyes | Series C | 0 |
10/2005 | EBR Systems | Series B | 21M |
11/2007 | Viracta Therapeutics | Series A | 20M |
3/2006 | Cartilix | Series B | 6.3M |
10/2008 | InSound Medical | Series E | 13M |
4/2010 | Articulinx Inc. | Series B | 10M |
11/2005 | FlowMedica | Series D | 0 |
10/2007 | Vitreoretinal Technologies | Series A | 12M |
4/2010 | Viracta Therapeutics | Series B | 12M |
11/2005 | Ovalis | Series A | 0 |
3/2011 | Astute Medical | Series B | 13M |
3/2012 | Viracta Therapeutics | Series B | 0 |
3/2004 | InSound Medical | Series D | 17.2M |
7/2008 | Sierra Surgical | Series B | 14.5M |
8/2007 | Sierra Surgical | Series A | 7.1M |
6/2004 | EBR Systems | Series A | 5.2M |
5/2007 | Pulmonx | Series B | 20M |
2/2011 | EBR Systems | Series D | 5M |
8/2001 | MicroVention Terumo | Series C | 12.5M |
5/2010 | Astute Medical | Series B | 26.5M |
10/2005 | PhotoThera | Series B | 19M |
3/2003 | iScience Surgical | Series B | 0 |
9/2011 | Simpirica Spine | Series C | 22M |
9/2013 | MyoScience | Series E | 0 |
3/2012 | MyoScience | Series D | 0 |
7/2008 | MyoScience | Series B | 0 |
6/2011 | Spinal Modulation | Series D | 0 |
8/2007 | EndoGastric Solutions | Series D | 30M |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
1/2016 | Benvenue Medical | Equity | 23M |
5/2007 | Talima Therapeutics | Series B | 19M |
7/2003 | Bacchus Vascular | Series D | 25M |
5/2009 | PhotoThera | Series D | 50M |
5/2014 | EndoGastric Solutions | Series G | 0 |
4/2006 | PhotoThera | Series C | 30.5M |
4/2006 | SynergEyes | Series B | 0 |
4/2017 | Avedro | Venture Round | 0 |
3/2005 | iScience Surgical | Series C | 0 |
6/2008 | EBR Systems | Series C | 35M |
1/2002 | Renovis | Series B | 0 |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
5/2009 | iScience Interventional | Series F | 20.5M |
5/2007 | TRIA Beauty | Series D | 0 |
1/2006 | Spinal Kinetics | Series B | 36M |
4/2012 | WaveTec Vision | Venture Round | 0 |
1/2008 | Avedro | Series A | 8M |
2/2011 | Spiracur | Series C | 35M |
12/2005 | Facet Solutions | Series B | 16.5M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
1/2003 | Lumend | Series D | 23.2M |
1/2008 | POINT Biomedical | Private Equity Round | 0 |
5/2018 | Avedro | Series F | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2016 | TearScience | Series D | 0 |
1/2016 | Benvenue Medical | Series F | 0 |
6/2014 | Benvenue Medical | Series E | 0 |
6/2014 | Spinal Kinetics | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | MyoScience | Series E | 0 |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|